PREGNANCY RATES IN IN VITRO FERTILIZATION CYCLES AFTER THE TRANSFER OF EMBRYOS WITH MOSAIC KARYOTYPE IN PATIENTS WITH ADVANCED MATERNAL AGE

Authors:

Abstract:

The technique of preimplantation genetic testing of embryos for aneuploidy makes it possible to select embryos with a balanced karyotype in case when assisted reproductive technologies are used. The literature provides data on the possibility of getting a normal pregnancy in patients when embryos with a low level of mosaicism of 20–40 % in the karyotype are transferred. The rates of blastocyst formation with balanced and mosaic karyotypes in women of different ages, and the clinical pregnancy rates after embryo transfer with mosaic karyotype in patients with advanced maternal age, were investigated in the present work. Increasing women's age was associated with decreased total blastocyst formation rate and the rate of blastocysts with high morphological quality (p=0.0044 and p=0.0190, respectively). Women aged 38 years or older are associated with an increased frequency of aneuploid embryo and blastocyst formation with a mosaic karyotype when using assisted reproductive technologies (p=0.00065 and p=0.0330, respectively). No statistically significant difference was found in clinical pregnancy rates between transferring embryos with a balanced karyotype and transferring blastocysts with a low level of mosaicism (p>0.05). A decrease in microscopic parameters of ejaculate leads to failures in the ability of sperm to fertilize a mature oocyte, even when the method of intracytoplasmic sperm injection was used when manipulating gametes in vitro (p=0.00504, p=0.000292, respectively).

Keywords:

preimplantation genetic testing for aneuploidy mosaicism clinical pregnancy assisted reproductive technologies

References:

1. Armstrong A, Kroener L, Miller J, Nguyen A, Kwan L, Quinn M. The nature of embryonic mosaicism across female age spectrum: an analysis of 21,345 preimplantation genetic testing for aneuploidy cycles. F&S Reports. 2023;4(3):256–261. https://doi.org/10.1016/j.xfre.2023.03.008.
2. Bamford T, Smith R, Young S, Evans A, Lockwood M, Easter C, et al. A comparison of morphokinetic models and morphological selection for prioritizing euploid embryos: a multicentre cohort study. Hum Reprod. 2024;39(1):53-61. doi: 10.1093/humrep/dead237.
3. Bland M. An Introduction to Medical Statistics. Oxford: Oxford University Press; 2015. 448 р.
4. Chung E, Atmoko W, Saleh R, Shah R, Agarwal A. Sixth edition of the World Health Organization laboratory manual of semen analysis:Updates and essential take away for busy clinicians, Arab Journal of Urology. 2024; 22:2, 71-74, DOI:10.1080/20905998.2023.2298048.
5. Cimadomo D, Fabozzi G, Vaiarelli A, Ubaldi N, Ubaldi FM, Rienzi L. Impact of maternal age on oocyte and embryo competence. Front Endocrinol (Lausanne). 2018;9:327. https://doi.org/10.3389/fendo.2018.00327.
6. Coticchio G, Ahlström A, Arroyo G, Balaban B, Campbell A, De Los Santos MJ et al. The Istanbul consensus update: a revised ESHRE/ALPHA consensus on oocyte and embryo static and dynamic morphological assessment. Hum Reprod. 2025:40(6):989-1035. doi: 10.1093/humrep/deaf021.
7. Doroftei B, Ilie O, Anton N, Armeanu T, Ilea C. A Mini-Review Regarding the Clinical Outcomes of In Vitro Fertilization (IVF) Following Pre-Implantation Genetic Testing (PGT)-Next Generation Sequencing (NGS) Approach. Diagnostics (Basel). 2022;12(8):1911. doi: 10.3390/diagnostics12081911.
8. Giudice F, Belladelli F, Chen T, Glover F, Mulloy EA, Kasman AM et al. The association of impaired semen quality and pregnancy rates in assisted reproduction technology cycles: Systematic review and meta-analysis. Andrologia. 2022; https://doi.org/10.1111/and.14409.
9. Korkmaz C, Tekin YB, Sakinci M, Ercan CM. Effects of maternal ageing on ICSI outcomes and embryo development in relation to oocytes morphological characteristics of birefringent structures. Zygote. 2015;23(4):550–5. https://doi.org/10.1017/S0967199414000197.
10. Nagy Z, Anderson R E, Feinberg EC, Hayward B, Mahony M C. The Human Oocyte Preservation Experience (HOPE) Registry: evaluation of cryopreservation techniques and oocyte source on outcomes. Reprod Biol Endocrinol.2017; 15(10). doi:10.1186/s12958-017-0228-7.
11. Pham TD, Dang VQ, Ho V, Tran CT, Nguyen D, Vuong LN et al. Intracytoplasmic sperm injection versus conventional in vitro fertilization in infertile couples with normal total sperm count and motility: does sperm morphology matter? Reproduction. 2025; 40(1): 23–29, https://doi.org/10.1093/humrep/deae252.
12. Vanni VS, Somigliana E, Reschini M, Pagliardini L, Marotta E, Faulisi S.Top quality blastocyst formation rates in relation to progesterone levels on the day of oocyte maturation in GnRH antagonist IVF/ICSI cycles. PLoS ONE.2017 12(5): e0176482. https://doi.org/10.1371/journal.pone.0176482.
13. Wasielak-Politowska M, Kordowitzki P. Chromosome Segregation in the Oocyte: What Goes Wrong during Aging. Int J Mol Sci. 2022;23(5):2880. doi: 10.3390/ijms23052880.
14. Zhang L, Wei D, Zhu Y, Gao Y, Yan J, Chen Z. Rates of live birth after mosaic embryo transfer compared with euploid embryo transfer. J Assist Reprod Genet. 2019;36(1):165–172. doi: 10.1007/s10815-018-1322-2.
15. Zhang YX, Chen JJ, Nabu S, Yeung Q, Li Y, Tan J, Suksalak W, Chanchamroen S, Quangkananurug W, Wong P, Chung J, Choy K. The Pregnancy Outcome of Mosaic Embryo Transfer: A Prospective Multicenter Study and Meta-Analysis. Genes (Basel). 2020;11(9):973. doi: 10.3390/genes11090973.

Publication:

«World of Medicine and Biology» Vol. 21 No. 94 (2025) , с. 127-131
УДК 618.177-089.888.11:611.013:57.043

DOI:

https://doi.org/10.26724/2079-8334-2025-4-94-127-131